Bimzelx (bimekizumab) - UCB
Cosentyx (secukinumab) - Novartis
Abrilada (adalimumab-afzb) - Pfizer
izokibep (ABY-035) - Affibody, ACELYRIN
Rinvoq (upadacitinib) - AbbVie
https://practicaldermatology.com/news/hs-update-studies-suggest-tnf-il-17-and-jak-inhibitors-may-play-a-role-in-treating-hs?c4src=home:recent-news
 
Mar 23, 2023
 
Prev Next